Pharsight

Drugs that contain Ribavirin

1. Rebetol patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6790837 SCHERING Ribavirin syrup formulations
Apr, 2023

(11 months ago)

US6790837

(Pediatric)

SCHERING Ribavirin syrup formulations
Oct, 2023

(5 months ago)

Market Authorisation Date: 29 July, 2003

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage

REBETOL family patents

Family Patents